Standard BioTools Inc. (LAB)
NASDAQ: LAB · Real-Time Price · USD
2.000
+0.015 (0.76%)
At close: Dec 20, 2024, 4:00 PM
1.900
-0.100 (-5.00%)
After-hours: Dec 20, 2024, 6:21 PM EST
Standard BioTools Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Standard BioTools stock have an average target of 2.88, with a low estimate of 2.50 and a high estimate of 3.25. The average target predicts an increase of 44.00% from the current stock price of 2.00.
Analyst Consensus: Strong Buy
* Price targets were last updated on Oct 31, 2024.
Analyst Ratings
The average analyst rating for LAB stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Strong Buy Maintains $2.75 → $2.5 | Strong Buy | Maintains | $2.75 → $2.5 | +25.00% | Oct 31, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $3.5 → $2.75 | Strong Buy | Maintains | $3.5 → $2.75 | +37.50% | Aug 1, 2024 |
| TD Cowen | TD Cowen | Strong Buy Initiates $3.5 | Strong Buy | Initiates | $3.5 | +75.00% | Apr 16, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $3.25 | Strong Buy | Initiates | $3.25 | +62.50% | Apr 4, 2024 |
| Keybanc | Keybanc | Buy Initiates $4 | Buy | Initiates | $4 | +100.00% | Jul 12, 2023 |
Financial Forecast
Revenue This Year
172.91M
from 106.34M
Increased by 62.60%
Revenue Next Year
190.05M
from 172.91M
Increased by 9.91%
EPS This Year
-0.53
from -0.94
EPS Next Year
-0.22
from -0.53
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 181.7M | 204.8M | 252.0M | |
| Avg | 172.9M | 190.1M | 226.5M | |
| Low | 166.6M | 180.8M | 209.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 70.8% | 18.4% | 32.6% | |
| Avg | 62.6% | 9.9% | 19.2% | |
| Low | 56.7% | 4.6% | 10.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.55 | -0.19 | -0.09 |
| Avg | -0.53 | -0.22 | -0.09 |
| Low | -0.51 | -0.25 | -0.09 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.